Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

EFTRW

eFFECTOR Therapeutics, Inc.

Healthcare · USD

Set alert

Price alert · EFTRW

All alert types
0.00 USD 0.00 0.00%
As of Nov 25, 2025
0.0006 Day range 0.0006
0.0006 52-week range 0.0006
Open
0.0006
Prev close
0.0006
Mkt cap
2.82K
Vol
40.11K
Avg vol
40.11K
EPS
-0.905
P/E
-0.00
Div yield
0.00%
More statistics
Low
0.0006
High
0.0006
Forward P/E
0.00
Beta
0.80
Short ratio
0.00
Inst. own
0.00%
Dividend
0.00
Ex-div date
50-d avg
0.00
200-d avg
0.00
1y target
0.00

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for EFTRW has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-13.59 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -0.7×
FY 2019: -0.5×FY 2020: 888×FY 2021: 21.2×FY 2022: -1.4×FY 2023: -0.7×
FY 2019 5y median -0.5× FY 2023
P/S 0.0×
FY 2019: 0.0×FY 2020: 3.5×FY 2021: 234×FY 2022: 5.0×FY 2023: 0.0×
FY 2019 5y median 3.5× FY 2023
P/B -4.4×
FY 2019: -1.0×FY 2020: 152×FY 2021: 19.3×FY 2022: 4.5×FY 2023: -4.4×
FY 2019 5y median 4.5× FY 2023
P/FCF -0.9×
FY 2019: -0.5×FY 2020: 10.9×FY 2021: -13.4×FY 2022: -0.7×FY 2023: -0.9×
FY 2019 5y median -0.7× FY 2023
EV/EBITDA -1.0×
FY 2019: -0.9×FY 2020: 9.1×FY 2021: 17.3×FY 2022: -1.4×FY 2023: -1.0×
FY 2019 5y median -0.9× FY 2023
EV/Sales 0.0×
FY 2019: 0.0×FY 2020: 3.5×FY 2021: 213×FY 2022: 8.2×FY 2023: 0.0×
FY 2019 5y median 3.5× FY 2023
FCF Yield -116.0%
FY 2019: -201.1%FY 2020: 9.2%FY 2021: -7.5%FY 2022: -148.2%FY 2023: -116.0%
FY 2019 5y median -116.0% FY 2023

Profitability

Gross Margin 0.0%
FY 2019: 0.0%FY 2020: 100.0%FY 2021: 98.3%FY 2022: 98.5%FY 2023: 0.0%
FY 2019 5y median 98.3% FY 2023
Operating Margin 0.0%
FY 2019: 0.0%FY 2020: 37.7%FY 2021: -2330.6%FY 2022: -912.0%FY 2023: 0.0%
FY 2019 5y median 0.0% FY 2023
Net Margin 0.0%
FY 2019: 0.0%FY 2020: 33.8%FY 2021: 1104.8%FY 2022: -363.8%FY 2023: 0.0%
FY 2019 5y median 0.0% FY 2023
ROE 618.0%
FY 2019: 214.9%FY 2020: 1451.6%FY 2021: 91.4%FY 2022: -331.8%FY 2023: 618.0%
FY 2019 5y median 214.9% FY 2023
ROIC -221.3%
FY 2019: -2034.5%FY 2020: 110.7%FY 2021: -66.5%FY 2022: -76.3%FY 2023: -221.3%
FY 2019 5y median -76.3% FY 2023
ROA -174.3%
FY 2019: -583.7%FY 2020: 85.1%FY 2021: 29.2%FY 2022: -44.5%FY 2023: -174.3%
FY 2019 5y median -44.5% FY 2023

Growth (YoY)

Revenue -100.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: -96.6%FY 2022: 148.5%FY 2023: -100.0%
FY 2019 FY 2023
Operating Income -4.4%
FY 2019: 0.0%FY 2020: 155.3%FY 2021: -310.7%FY 2022: 2.8%FY 2023: -4.4%
FY 2019 FY 2023
EPS (diluted) -108.5%
FY 2019: 0.0%FY 2020: 100.0%FY 2021: 9680.0%FY 2022: -180.3%FY 2023: -108.5%
FY 2019 FY 2023
Free Cash Flow -13.6%
FY 2019: 0.0%FY 2020: 149.6%FY 2021: -282.2%FY 2022: -4.7%FY 2023: -13.6%
FY 2019 FY 2023

Financial Health

Current Ratio 0.8×
FY 2019: 0.2×FY 2020: 1.9×FY 2021: 13.3×FY 2022: 1.1×FY 2023: 0.8×
FY 2019 5y median 1.1× FY 2023
Quick Ratio 0.8×
FY 2019: 0.2×FY 2020: 1.9×FY 2021: 13.3×FY 2022: 1.1×FY 2023: 0.8×
FY 2019 5y median 1.1× FY 2023
Debt / Equity -3.5×
FY 2019: -1.1×FY 2020: 13.2×FY 2021: 1.2×FY 2022: 5.2×FY 2023: -3.5×
FY 2019 5y median 1.2× FY 2023
Net Debt / EBITDA -0.2×
FY 2019: -0.4×FY 2020: -0.1×FY 2021: -1.7×FY 2022: -0.6×FY 2023: -0.2×
FY 2019 5y median -0.4× FY 2023
Interest Coverage -11.6×
FY 2019: -20.7×FY 2020: 11.9×FY 2021: -18.9×FY 2022: -14.4×FY 2023: -11.6×
FY 2019 5y median -14.4× FY 2023

Dividends

Dividend Yield 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%
FY 2019 5y median 0.0% FY 2023
Payout Ratio 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%
FY 2019 5y median 0.0% FY 2023

Annual · latest fiscal year ends 2023-12-31